HER WELL JOURNAL//LABS // INGREDIENT DATABASE
HER WELL JOURNAL LABS // INGREDIENT DATABASE

Black Cohosh: Review for Hot Flashes

CAS NO: 84776-26-1 | METABOLIC TARGET: Central serotonin receptor modulation, hypothalamic thermoregulation
TIER 1 (HUMAN RCTS)
⚕️ Medical DisclaimerThe database profiles and clinical trial breakdowns shared by Her Well Journal Labs are for educational purposes only. They do not constitute medical advice, diagnosis, or treatment. Always consult with your physician, endocrinologist, or qualified healthcare provider regarding any dietary supplement, active compound protocol, or metabolic concern.

Black Cohosh (Actaea racemosa) is the most extensively researched botanical intervention for perimenopausal and menopausal vasomotor symptoms (hot flashes and night sweats). While historically classified as a phytoestrogen, modern clinical trials have clarified its pharmacology as a central nervous system modulator that acts on serotonin and dopamine pathway receptors.

Mechanism of Action (Vasomotor Stabilization)

During the menopausal estrogen decline, the hypothalamus experiences a narrowing of the thermoregulatory zone. This is primarily mediated by shifting neurotransmitter levels (specifically serotonin and norepinephrine).

Standardized Black Cohosh extract modulates central pathways:

  • Serotonergic Receptor Activity: Active triterpene glycosides bind to hypothalamic serotonin receptors (specifically the 5-HT1A and 5-HT7 subtypes), mimicking the stabilizing effects of estrogen on the brain’s thermostat.
  • Selective Tissue Action: Black Cohosh does not exhibit stimulatory estrogenic effects on peripheral tissues such as breast tissue or endometrium, making it a safer option for women with contraindications to systemic hormone therapy.

Human Clinical Trial Registry

TRIAL ID: PMID 16047154 (Double-Blind RCT)

  • Study Design: 12-week randomized, double-blind, placebo-controlled trial evaluating standardized Black Cohosh extract.
  • Dosage: 40 mg daily (standardized extract containing 2.5% triterpene glycosides).
  • Outcomes: Demonstrated a significant reduction (up to 50%) in both hot flash frequency and severity compared to placebo, alongside improved mood scores.

TRIAL ID: PMID 23253456 (Systematic Review & Meta-Analysis)

  • Study Design: Meta-analysis of multiple randomized controlled trials.
  • Outcomes: Confirmed that standardized Black Cohosh formulations provide superior vasomotor relief compared to placebo, with a safety profile comparable to control groups.

Clinical Verdict

Standardized Black Cohosh extract is a Tier 1 evidence-based non-hormonal option for managing vasomotor symptoms. Formulations must use standardized extracts to ensure triterpene glycoside concentration.

REVIEWED PRODUCTS USING THIS INGREDIENT
Best Black Cohosh Supplements for Hot Flashes
LAB VERDICT: PASS
View Lab Verdict ➜